Sato, A.; Takagi, K.; Yoshida, M.; Yamaguchi-Tanaka, M.; Sagehashi, M.; Miki, Y.; Miyashita, M.; Suzuki, T.
Discoidin Domain Receptor 2 Contributes to Breast Cancer Progression and Chemoresistance by Interacting with Collagen Type I. Cancers 2024, 16, 4285.
https://doi.org/10.3390/cancers16244285
AMA Style
Sato A, Takagi K, Yoshida M, Yamaguchi-Tanaka M, Sagehashi M, Miki Y, Miyashita M, Suzuki T.
Discoidin Domain Receptor 2 Contributes to Breast Cancer Progression and Chemoresistance by Interacting with Collagen Type I. Cancers. 2024; 16(24):4285.
https://doi.org/10.3390/cancers16244285
Chicago/Turabian Style
Sato, Ai, Kiyoshi Takagi, Momoka Yoshida, Mio Yamaguchi-Tanaka, Mikoto Sagehashi, Yasuhiro Miki, Minoru Miyashita, and Takashi Suzuki.
2024. "Discoidin Domain Receptor 2 Contributes to Breast Cancer Progression and Chemoresistance by Interacting with Collagen Type I" Cancers 16, no. 24: 4285.
https://doi.org/10.3390/cancers16244285
APA Style
Sato, A., Takagi, K., Yoshida, M., Yamaguchi-Tanaka, M., Sagehashi, M., Miki, Y., Miyashita, M., & Suzuki, T.
(2024). Discoidin Domain Receptor 2 Contributes to Breast Cancer Progression and Chemoresistance by Interacting with Collagen Type I. Cancers, 16(24), 4285.
https://doi.org/10.3390/cancers16244285